Option Care Health (NASDAQ:OPCH) Releases Earnings Results, Beats Expectations By $0.03 EPS

Option Care Health (NASDAQ:OPCH) posted its earnings results on Thursday. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03, FiscalAI reports. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same quarter last year, the firm earned $0.40 earnings per share. The company’s revenue was up 1.3% on a year-over-year basis. Option Care Health updated its FY 2026 guidance to 1.820-1.920 EPS.

Here are the key takeaways from Option Care Health’s conference call:

• The company revised full-year net revenue guidance down to $5.675B–$5.775B (≈1% growth at midpoint) and now expects an approximately $55 million gross profit headwind from the CID/Stelara patient reset.
• Acute therapies and IG‑neuro were strong in Q1 (acute revenue grew high single digits) and ambulatory clinic utilization improved (visits +14% YoY; 34% of nursing visits in suites/clinics), supporting higher-margin growth vectors.
• Management kept full-year adjusted EBITDA guidance at $480M–$505M and adjusted EPS at $1.82–$1.92 despite the revenue cut, citing cost reductions, variable cost discipline, and sequential momentum beginning in Q2.
• Q1 saw a doubling of benefit reverification/reauthorization work that extended into late March, causing a larger-than-expected chronic patient census decline and some patient losses to competitors or self-administration that will take time to recover.
• Financial flexibility improved with net leverage at 2.2x, the revolver expanded to $850M, >$17M of share repurchases in Q1, and continued focus on organic investment and targeted M&A to support recovery and growth.

Option Care Health Price Performance

OPCH stock traded down $0.30 during midday trading on Friday, reaching $20.03. The company had a trading volume of 6,371,673 shares, compared to its average volume of 2,412,801. The company has a market capitalization of $3.14 billion, a price-to-earnings ratio of 15.65, a price-to-earnings-growth ratio of 1.14 and a beta of 0.68. The stock has a 50 day moving average price of $29.15 and a 200-day moving average price of $30.69. Option Care Health has a 1-year low of $18.01 and a 1-year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 0.96.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Stephens set a $30.00 price target on Option Care Health in a research note on Friday. Jefferies Financial Group reaffirmed a “buy” rating and issued a $37.00 price target on shares of Option Care Health in a research note on Tuesday, January 13th. National Bank Financial set a $37.00 price target on Option Care Health in a research note on Tuesday, January 27th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $26.00 price target on shares of Option Care Health in a research note on Friday. Finally, Citizens Jmp reaffirmed a “market outperform” rating and issued a $38.00 price target (up from $36.00) on shares of Option Care Health in a research note on Tuesday, January 13th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average target price of $32.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of OPCH. Royal Bank of Canada grew its position in Option Care Health by 20.7% in the first quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after acquiring an additional 39,661 shares during the last quarter. AQR Capital Management LLC grew its position in Option Care Health by 162.6% in the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock valued at $1,450,000 after acquiring an additional 25,777 shares during the last quarter. Empowered Funds LLC bought a new position in Option Care Health in the first quarter valued at about $208,000. Invesco Ltd. grew its position in Option Care Health by 2.7% in the second quarter. Invesco Ltd. now owns 294,363 shares of the company’s stock valued at $9,561,000 after acquiring an additional 7,678 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in Option Care Health by 528.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after acquiring an additional 1,183 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health News Summary

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: EPS/operating results had some upside or in‑line elements (reported EPS near/above consensus per several services), which is a partial offset to the headline weakness. MarketBeat earnings note
• Neutral Sentiment: Option Care issued FY‑2026 EPS guidance of $1.82–$1.92 (roughly in line with consensus) and provided a slide deck and conference call — limiting clarity on margin/profit trajectory but not eliminating uncertainty. GlobeNewswire press release
• Negative Sentiment: The company missed revenue estimates for Q1 ($1.35B reported vs. ~$1.40B consensus) and lowered full‑year revenue guidance to $5.7–$5.8B (vs. ~$5.9B consensus), a direct driver of the share decline. Yahoo Markets article
• Negative Sentiment: Multiple law firms have announced investigations into Option Care for potential securities‑law violations following the Q1 release, increasing legal and disclosure risk for shareholders. Block & Leviton alert Levi & Korsinsky alert
• Negative Sentiment: Analysts have reacted: TD Cowen cut its price target from $37 to $23 and placed a “hold”, and Bank of America downgraded OPCH from “buy” to “neutral” (PT $22), reflecting increased caution from the sell‑side. Benzinga note
• Negative Sentiment: Shares experienced heavier-than-normal volume and a sharp intraday decline after the results and guidance cut, indicating weak near‑term investor sentiment and heightened selling pressure. Seeking Alpha coverage

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.